Why the study?
Patients with preexisting cardiovascular disease have lower breastfeeding rates, and concerns regarding lactation safety and medication exposure may cause early breastfeeding cessation.
Are common cardiac medications safe during lactation in mothers with preexisting cardiovascular disease?
Are common cardiac medications safe during lactation in mothers with preexisting cardiovascular disease?
Enhancing provider knowledge regarding the pharmacokinetics and safety of cardiac medications during breastfeeding can guide shared decision-making and potentially improve lactation outcomes in patients with cardiovascular disease.
Answers are grounded in this paper and cite their sources.
Captured external expert commentary on this paper, strongest first. Original sources are linked where available.
“The primary goal is to maintain cardiac stability in the birthing parent while minimizing fetal risk, requiring a careful balance of medications to effectively control HF symptoms without adversely affecting fetal development.”
Clinicians should discuss lactation medication safety with CVD patients to support breastfeeding; leaves open specific barriers requiring further targeted research.
Breastfeeding is the gold standard for infant feeding with well-established maternal, neonatal, and pediatric benefits. Patients with preexisting cardiovascular disease have lower breastfeeding rates than the general population. While little evidence exists regarding specific barriers to lactation in patients with preexisting cardiovascular disease, concerns regarding lactation safety and medication exposure in mothers with cardiovascular disease may be a cause for early breastfeeding cessation despite known health benefits. This literature review highlights the lactation safety of common cardiac medications. While some common cardiac medications may have limited safety data available, general pharmacokinetic principles of drug secretion in lactation can help to guide shared decision making in discussion with the patient. Enhancing provider knowledge regarding cardiac medication safety during breastfeeding may improve lactation outcomes in this population.
Journal, society, and media accounts. Useful signal, not independent expert judgment.
No takes yet. Share an insight, caveat, or question.
Nunez-Pellot et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: